← Back to overview

CAH Cardinal Health, Inc.

Health Care Distributors · $228.03 +0.91%
EN PL
Price Alert:

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
81.2
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
124.16 / 88.39 / —
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
39.81 / 27.20
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
34.9
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
53.41B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
0.90%
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
137.75 – 243.21
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Cardinal Health, Inc. is trading at $228.03, +0.91% versus the previous close. The price is near its 52-week high — the top of its recent trading range.
Overbought territory (RSI > 70) — the stock has risen quickly and could be due for a pause.
MACD is above its signal line — momentum currently leans positive.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

Ecolab Gears Up to Report Q2 Results: How to Play the Stock?
Zacks · 2026-07-24 17:16
Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
Zacks · 2026-07-24 15:24
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?
Zacks · 2026-07-24 15:21
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Zacks · 2026-07-24 15:09
Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs
Zacks · 2026-07-24 15:05
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
Zacks · 2026-07-24 14:00
Do Cardinal Health’s New Home-Health Deals Reshape the Bull Case for CAH?
Simply Wall St. · 2026-07-24 07:17
WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth
Zacks · 2026-07-23 18:08
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.